SciClone Pharmaceuticals: Caged by the Elephant
SciClone Pharmaceuticals is a China-based company that has filed to list on the HKEX. We expect concerns about VBP for Zadaxin to weigh on the...
314 Views
China Healthcare Weekly (Feb.5)
This article analyzed the results of the 4th volume-based purchase, the CTLA-4 antibody drug industry, the orthopedic implant device market, news...
211 Views
BeiGene: Novartis Grabs Tislelizumab Rights
BeiGene's deal with Novartis for PD-1 tislelizumab validates its competitive position, and marks a rising trend of Chinese companies licensing...
274 Views
Eddingpharm: First Impressions
Eddingpharm plans to list on the HKEX. This Insight analyzes the company's products and pipeline. The main question is whether enthusiasm for the...
383 Views
Smartkarma Originals
Short-Sell Strategies – How to Get Teflon Coated?
This insight has been produced jointly by Shifara Samsudeen, ACMA, CGMA and Supun Walpola at LightStream Research In this Smartkarma...
903 Views